Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for David Penson

4 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Diagnostic

    VICCURO15140

    01/18/2016

    Analysis of Cell-Free DNA (cfDNA) in Men with Elevated PSA Levels

    Health Services Research

    VICCURO1589

    03/16/2016

    A Prospective Observational Cohort Study of Patients with Castration- Resistant Prostate Cancer (CRPC) in the United States

    Treatment

    VICCURO1677

    08/09/2016

    Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients with Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study

    Treatment

    VICCURO1540

    07/08/2015

    A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men with High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy. MDV3100-13


    Print this page for your doctor